Denver, CO, November 26, 2007 --(PR.com
)-- Baxa Corporation is sponsoring a professional presentation discussing the differences between standardized parenteral nutrition (PN) formulations and a standardized process for PN systems. The Exhibitor’s Theatre presentation, “The Pros and Cons of Standardized Parenteral Nutrition,” describes safety issues surrounding the PN nutrition process, and details key research into the benefits and risks of custom vs. standardized PN formulations. The program takes place on Monday, December 3rd at the meeting of the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting at the Sands Expo Center in Las Vegas.
Presenter Gordon S. Sacks, PharmD, FCCP, BCNSP is currently a Clinical Professor at the University of Wisconsin – Madison, and Chair of the Pharmacy Practice Division in the School of Pharmacy. He also serves as Coordinator of the Surgical Nutrition Support Team at the University of Wisconsin Hospital and Clinics in Madison, WI. Active in numerous scientific and professional societies, Dr. Sacks is a member of the American Society for Parenteral and Enteral Nutrition (ASPEN) and has held offices in both its national and state organizations. The program builds on Sacks’ knowledge of regulatory and clinical requirements for safe PN systems, providing recommendations for the components of a standardized process and guidance on the roles and responsibilities of pharmacists in promoting best practice.
The complimentary, one-hour educational program will be held Monday, December 3rd in Palazzo Ballroom C, of the Sands Expo Center, beginning at 11:15 AM. Participants are eligible for one credit hour of Pharmacy Continuing Education (CEU).
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of fluid medications. Key products include Rapid-Fill™ Automated Syringe Fillers, Exacta-Med® Oral Dispensers, MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, and Exacta-Mix™ and MicroMacro™ Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at http://www.baxa.com
Marian Robinson, Vice President, Marketing
Baxa Corporation http://www.baxa.com – 800.567.2292 ext. 2157 or 303.617.2157
Maggie Chamberlin Holben, APR
Absolutely Public Relations http://www.absolutelypr.com – 303.984.9801 or 303.669.3558